BIO
Heather
Rosecrans
Executive Vice President of Medical Devices & Combination Products
MDMA & Eliquent Life Sciences
Heather Rosecrans brings more than 40 years of public health, and particularly medical device experience, to MDMA and ELIQUENT Life Sciences. Prior to joining MDMA and ELIQUENT, Heather spent 33+ years at the U.S. FDA’s Center for Devices and Radiological Health (CDRH). Heather served for her last 18 years at CDRH as Director of the Premarket Notification (510(k)) Staff. In this role, she was responsible for implementing administrative and regulatory policy for the 510(k) Program, the 513(g) Program, Classification and Reclassification, de novo petitions and other premarket regulatory requirements.
